Success Metrics

Clinical Success Rate
100.0%

Based on 12 completed trials

Completion Rate
100%(12/12)
Active Trials
0(0%)
Results Posted
8%(1 trials)

Phase Distribution

Ph phase_2
5
31%
Ph phase_3
3
19%
Ph phase_4
7
44%

Phase Distribution

0

Early Stage

5

Mid Stage

10

Late Stage

Phase Distribution15 total trials
Phase 2Efficacy & side effects
5(33.3%)
Phase 3Large-scale testing
3(20.0%)
Phase 4Post-market surveillance
7(46.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

12 of 12 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

16

all time

Status Distribution
Active(1)
Completed(12)
Other(3)

Detailed Status

Completed12
unknown3
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
16
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 25 (33.3%)
Phase 33 (20.0%)
Phase 47 (46.7%)

Trials by Status

unknown319%
completed1275%
not_yet_recruiting16%

Recent Activity

0 active trials
Showing 5 of 16
not_yet_recruitingphase_4

Topical Diacerein in Psoriasis Vulgaris

NCT07352306
completedphase_3

Effect of Diacerein vs Celecoxib on Symptoms and Structural Changes in Symptomatic Knee Osteoarthritis

NCT02688400
unknownphase_2

Study Design of the Diacerein in Patients With Covid-19

NCT05226754
completed

Efficacy of Diacerein on Ocular Surface Disease in Degenerative Arthritis Patients

NCT04351100
completedphase_3

Efficacy Study of Diacerein on Glycemic Control and Liver Fat in Type 2 Diabetes Subjects

NCT02242149
View all 16 trials

Clinical Trials (16)

Showing 16 of 16 trials
NCT07352306Phase 4

Topical Diacerein in Psoriasis Vulgaris

Not Yet Recruiting
NCT02688400Phase 3

Effect of Diacerein vs Celecoxib on Symptoms and Structural Changes in Symptomatic Knee Osteoarthritis

Completed
NCT05226754Phase 2

Study Design of the Diacerein in Patients With Covid-19

Unknown
NCT04351100

Efficacy of Diacerein on Ocular Surface Disease in Degenerative Arthritis Patients

Completed
NCT02242149Phase 3

Efficacy Study of Diacerein on Glycemic Control and Liver Fat in Type 2 Diabetes Subjects

Completed
NCT03404479Phase 4

Trial to Evaluate Efficacy and Safety of Combination of Diacerein and Celecoxib Administered in Patients With Knee OA

Unknown
NCT03208309Phase 2

Effect of Diacerein in the Metabolic Control of Patients With DM Type 2 and Secondary Failure to Metformin

Completed
NCT01906801Phase 4

Clinical Efficacy of Glucosamine Plus Diacerein Versus Mono-therapy of Glucosamine

Completed
NCT01264211Phase 2

Safety and Efficacy of the Combination of Diacerein 100 mg Daily and MTX Versus MTX Alone in the Treatment of Early Rheumatoid Arthritis (RA)

Completed
NCT02177643Phase 2

Effect of Diacerein in the Metabolic Control of Patients With DM Type 2 and Secondary Failure to Metformin

Unknown
NCT02060552Phase 4

Immune Molecular and Inflammatory Cytokines Dysfunction Analysis in Gout Patients With Different Urate Levels

Completed
NCT01298882Phase 2

Diacerein on Insulin Secretion in Diabetes

Completed
NCT00685542Phase 4

Effect of Diacerein on Hand Osteoarthritis

Completed
NCT01120015Phase 4

Diacerein as Adjuvant to Diclofenac Sodium in Indian Patients of Osteoarthritis (OA) Knee

Completed
NCT00445276Phase 4

Symptomatic Efficacy of Diacerein in Knee Osteoarthritis

Completed
NCT00451360Phase 3

Chondromodulating Effect of Diacerein in Osteoarthritis of the Hip

Completed

All 16 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
16